MR编号 | DE/V/0159/001 |
---|
药品名称 | Spasmium compositum |
---|
活性成分 | - hyoscine butylbromide 4.0 mg/ml
- metamizole sodium monohydrate 500.0 mg/ml
|
---|
剂型 | Solution for injection |
---|
上市许可持有人 | Richter Pharma AG |
---|
参考成员国 - 产品名称 | Germany (DE) Spasmium compositum |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Iceland (IS)
Spasmium vet. 500 mg/ml + 4 mg ml Stungulyf, lausn handa hestum, nautgripum, svínum og hundum - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
Spasmium Compositum 500.0mg/ml/4.0mg/ml Solution for Injection - Austria (AT)
Spasmium comp. 500 mg/ml + 4 mg/ml Injektionslösung für Tiere - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
Spasmium vet - Finland (FI)
- Poland (PL)
- Latvia (LV)
Spasmium comp. 500 mg/ml + 4 mg/ml - Lithuania (LT)
- Estonia (EE)
Spasmium comp. - Hungary (HU)
- Bulgaria (BG)
- Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Croatia (HR)
|
---|
许可日期 | 2015/06/17 |
---|
最近更新日期 | 2024/07/26 |
---|
药物ATC编码 | - QA03BB01 butylscopolamine
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|